These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9916625)

  • 1. Results of evaluation of the quality of HLA typing in the Czech Republic.
    Ivasková E; Sajdlová H; Bendukidze N; Kupková L; Hána I; Vítko S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S17-9. PubMed ID: 9916625
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality control for registry HLA data.
    Tiercy JM; Fischer G; Setterholm M
    Tissue Antigens; 2007 Apr; 69 Suppl 1():13-4. PubMed ID: 17445155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of a national bone marrow donor registry: results of a pilot study and proposal for a standardized approach.
    Tiercy JM; Stadelmann S; Chapuis B; Gratwohl A; Schanz U; Seger RA; Faveri GN; Kern M; Morell A; Schwabe R; Schneider P
    Bone Marrow Transplant; 2003 Sep; 32(6):623-7. PubMed ID: 12953136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sixth quality control exercise of the Central European tissue typing laboratories.
    Fischer G; Kreuzer D; Beer U; Gleissner B; Wasilewski K; Faé I
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S14-6. PubMed ID: 9916624
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of the HLA proficiency testing for Central and East Europe.
    Bogunia-Kubik K; Lange A
    Int J Immunogenet; 2008 Aug; 35(4-5):409-16. PubMed ID: 18976448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histocompatibility tests in a transplantation program].
    de-Leo-Cervantes C
    Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Do we have a sufficient supply of anti-HLA serum? Review of sera produced by the transfusion service 1974-1992].
    Májský A
    Vnitr Lek; 1993 Sep; 39(9):883-6. PubMed ID: 8212642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of confirmatory testing of HLA system in unrelated haematopoietic stem cell donors].
    Dobrovolná M; Vraná M; Brdicka R; Loudová M
    Cas Lek Cesk; 2006; 145(1):32-5. PubMed ID: 16468239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of proficiency testing for laboratories involved in cadaveric organ transplantation and its consequences for graft survival.
    Doxiadis II; Witvliet M; Verduyn W; de Lange P; Tanke J; Schreuder GM; Persijn GG; Claas FH
    Clin Transpl; 2000; ():99-103. PubMed ID: 11512364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [National quality control of genomic HLA typing].
    Ferrara GB
    Ann Ist Super Sanita; 1999; 35(1):45-9. PubMed ID: 10645644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality control for HLA typing].
    Bogunia-Kubik K; Łaba A; Lange A
    Postepy Hig Med Dosw; 2000; 54(6):759-66. PubMed ID: 11227374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [National quality control of serologic HLA typing].
    Quintieri F; Pugliese O; Mariani M
    Ann Ist Super Sanita; 1999; 35(1):41-4. PubMed ID: 10645643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for new donor typing based on donor HLA type or donor characteristics.
    Little AM; Jindra P; Raffoux C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():8-9. PubMed ID: 17445153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLAMatchmaker-based definition of structural human leukocyte antigen epitopes detected by alloantibodies.
    Duquesnoy RJ; Marrari M
    Curr Opin Organ Transplant; 2009 Aug; 14(4):403-9. PubMed ID: 19417654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation with unrelated donors: what is the probability of identifying an HLA-A/B/Cw/DRB1/B3/B5/DQB1-matched donor?
    Tiercy JM; Bujan-Lose M; Chapuis B; Gratwohl A; Gmür J; Seger R; Kern M; Morell A; Roosnek E
    Bone Marrow Transplant; 2000 Aug; 26(4):437-41. PubMed ID: 10982291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concerning: Thiel G: Kidney transplantation and HLA-matching: Do Swiss guidelines deserve to be changed? (Schweiz Med Wochenschr 1995; 125:1571-1572)].
    Frick T; Speiser D
    Schweiz Med Wochenschr; 1996 Jan; 126(4):140. PubMed ID: 8578296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Status and developmental prospects for a typing service for bone marrow transplantation in the Ukraine].
    Timoshenko LI
    Vrach Delo; 1981 May; (5):84-7. PubMed ID: 7020245
    [No Abstract]   [Full Text] [Related]  

  • 19. Serological versus molecular HLA-DR typing of cadaveric donors in conditions of Regional Tissue Typing Laboratory.
    Cermaková Z; Kolariková H
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S47-8. PubMed ID: 9916634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.